FTIH of ECC5004 in Healthy and Diabetic Participants

NCT05654831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Placebo
DRUG: ECC5004

Sponsor

Eccogene